ArticlePloS one2024

Rationale and protocol for a safety, tolerability and feasibility randomized, parallel arm, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanisms.

Brianna J Stubbs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.